Lewis-Sumner syndrome associated with infliximab therapy for psoriasis

An Bras Dermatol. 2017 Jan-Feb;92(1):156-157. doi: 10.1590/abd1806-4841.20176151.

Authors

Karen Fernandes de Oliveira¹, Gladys Aires Martins¹, Keila Rejane Ferreira Galvão², Patricia Shu Kurizky¹

Affiliations

¹ Department of Dermatology, Hospital Universitário de Brasília at Universidade de Brasília (HUB-UnB) - Brasília (DF), Brazil.
² Department of Neurology, Hospital Universitário de Brasília at Universidade de Brasília (HUB-UnB) - Brasília (DF), Brazil.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Demyelinating Diseases / chemically induced*
Dermatologic Agents / adverse effects*
Humans
Infliximab / adverse effects*
Male
Motor Disorders / chemically induced*
Psoriasis / drug therapy*
Sensation Disorders / chemically induced*
Syndrome
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Dermatologic Agents
Tumor Necrosis Factor-alpha
Infliximab